McCarthy J, Finnegan L
Front Pediatr. 2024; 11:1316583.
PMID: 38188918
PMC: 10768019.
DOI: 10.3389/fped.2023.1316583.
Cernasev A, Hohmeier K, Frederick K, Jasmin H, Gatwood J
Explor Res Clin Soc Pharm. 2022; 2:100029.
PMID: 35481114
PMC: 9029901.
DOI: 10.1016/j.rcsop.2021.100029.
Chalabianloo F, Fadnes L, Hoiseth G, Ohldieck C, Vold J, Aas C
Subst Abuse Treat Prev Policy. 2021; 16(1):39.
PMID: 33941217
PMC: 8091668.
DOI: 10.1186/s13011-021-00367-w.
Cernasev A, Veve M, Cory T, Summers N, Miller M, Kodidela S
Pharmacy (Basel). 2020; 8(3).
PMID: 32932786
PMC: 7559328.
DOI: 10.3390/pharmacy8030168.
Vatter T, Klumpp L, Ganser K, Stransky N, Zips D, Eckert F
Biomolecules. 2020; 10(6).
PMID: 32560384
PMC: 7356722.
DOI: 10.3390/biom10060917.
Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.
Neale J, Tompkins C, McDonald R, Strang J
Addiction. 2018; 113(6):1066-1076.
PMID: 29356208
PMC: 5969063.
DOI: 10.1111/add.14163.
Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.
Majer J, Beasley C, Stecker E, Bobak T, Norris J, Nguyen H
Community Ment Health J. 2018; 54(5):571-577.
PMID: 29302767
DOI: 10.1007/s10597-017-0218-4.
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith A, Jensen K, Li J, Nunez Y, Farrer L, Hakonarson H
Mol Psychiatry. 2017; 22(3):346-352.
PMID: 28115739
PMC: 5407902.
DOI: 10.1038/mp.2016.257.
Incubation of Methamphetamine but not Heroin Craving After Voluntary Abstinence in Male and Female Rats.
Venniro M, Zhang M, Shaham Y, Caprioli D
Neuropsychopharmacology. 2016; 42(5):1126-1135.
PMID: 28025975
PMC: 5506794.
DOI: 10.1038/npp.2016.287.
Native Transformations in the Pacific Northwest: A strength-based model of protection against substance use disorder.
Rasmus S, Allen J, Connor W, Freeman W, Skewes M
Am Indian Alsk Native Ment Health Res. 2016; 23(3):158-86.
PMID: 27383091
PMC: 4955863.
DOI: 10.5820/aian.2303.2016.158.
An Examination of Women Ex-Offenders With Methadone Histories.
Majer J, Harris J, Jason L
Int J Offender Ther Comp Criminol. 2015; 61(6):711-723.
PMID: 26275413
PMC: 5553198.
DOI: 10.1177/0306624X15600834.
Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.
Shiran M, Hosseinzadeh R, Hamidikenari A, Zarghami M, Lamsehchi N, Rafati M
Iran J Psychiatry Behav Sci. 2014; 5(2):53-61.
PMID: 24644447
PMC: 3939965.
Comparison of General Well-being of Patients Undergoing Methadone Maintenance Therapy (MMT) with Patients Undergoing Naltrexone Therapy.
Sayyah M, Sharifi M, Rokni P
Iran J Public Health. 2013; 42(2):145-8.
PMID: 23515429
PMC: 3595655.
Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.
Tetrault J, Fiellin D
Drugs. 2012; 72(2):217-28.
PMID: 22235870
PMC: 3701303.
DOI: 10.2165/11597520-000000000-00000.
Opioids and HIV/HCV infection.
Wang X, Zhang T, Ho W
J Neuroimmune Pharmacol. 2011; 6(4):477-89.
PMID: 21755286
PMC: 3937260.
DOI: 10.1007/s11481-011-9296-1.
Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy.
Mohamad N, Abu Bakar N, Musa N, Talib N, Ismail R
Harm Reduct J. 2010; 7:30.
PMID: 21167035
PMC: 3019202.
DOI: 10.1186/1477-7517-7-30.
The case for chronic disease management for addiction.
Saitz R, Larson M, LaBelle C, Richardson J, Samet J
J Addict Med. 2011; 2(2):55-65.
PMID: 19809579
PMC: 2756688.
DOI: 10.1097/ADM.0b013e318166af74.
Development of pharmacotherapies for drug addiction: a Rosetta stone approach.
Koob G, Lloyd G, Mason B
Nat Rev Drug Discov. 2009; 8(6):500-15.
PMID: 19483710
PMC: 2760328.
DOI: 10.1038/nrd2828.
Steady-state methadone effect on generalized arousal in male and female mice.
Devidze N, Zhou Y, Ho A, Zhang Q, Pfaff D, Kreek M
Behav Neurosci. 2008; 122(6):1248-56.
PMID: 19045944
PMC: 2672421.
DOI: 10.1037/a0013276.
Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.
Haney M
Addict Biol. 2008; 14(1):9-21.
PMID: 18855806
PMC: 2743289.
DOI: 10.1111/j.1369-1600.2008.00121.x.